May 25, 2023
On May 25, 2023, Illumina, a global leader in DNA sequencing and array‑based technologies, announced that Illumina shareholders have voted to elect eight of nine Illumina director nominees to the Board of Directors. Cravath represented Illumina in connection with these matters.
The Cravath team was led by partners Faiza J. Saeed, Ting S. Chen and Daniel J. Cerqueira and included associates Saagar Kaul, Joseph A. Marshall and Brianna Pang Sawhney on corporate and activist defense matters; partners Michael L. Arnold and Kimberley S. Drexler and associate Filareti Kouimtzi Filaretou corporate governance matters; and partner Matthew J. Bobby, practice area attorney Aaron S. Cha and associate Molly E. Nichols on executive compensation and benefits matters. Carly B. Sadicario also worked on corporate and activist defense matters.
Deals & Cases
September 02, 2022
On September 1, 2022, Chief Administrative Law Judge D. Michael Chappell of the Federal Trade Commission (“FTC”) ruled in favor of Cravath client Illumina, rejecting the FTC’s challenge to Illumina’s $8 billion acquisition of GRAIL, which closed in August 2021.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.